Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID O95644 4772 NFATC1 NFAT2 NFATC Lymphoid neoplasm diffuse large B-cell lymphoma Methylation N R23 O95644 4772 NFATC1 NFAT2 NFATC Bladder urothelial carcinoma Phosphorylation N S117 O95644 4772 NFATC1 NFAT2 NFATC Breast invasive carcinoma Phosphorylation N S151 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N S151 O95644 4772 NFATC1 NFAT2 NFATC Hepatocellular carcinoma Phosphorylation N S151 O95644 4772 NFATC1 NFAT2 NFATC Stomach adenocarcinoma Phosphorylation N S151 O95644 4772 NFATC1 NFAT2 NFATC Uterine corpus endometrial carcinoma Phosphorylation N S151 O95644 4772 NFATC1 NFAT2 NFATC Breast invasive carcinoma Phosphorylation N S153 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N S153 O95644 4772 NFATC1 NFAT2 NFATC Hepatocellular carcinoma Phosphorylation N S153 O95644 4772 NFATC1 NFAT2 NFATC Stomach adenocarcinoma Phosphorylation N S153 O95644 4772 NFATC1 NFAT2 NFATC Uterine corpus endometrial carcinoma Phosphorylation N S153 O95644 4772 NFATC1 NFAT2 NFATC Breast invasive carcinoma Phosphorylation N T154 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N T154 O95644 4772 NFATC1 NFAT2 NFATC Hepatocellular carcinoma Phosphorylation N T154 O95644 4772 NFATC1 NFAT2 NFATC Stomach adenocarcinoma Phosphorylation N T154 O95644 4772 NFATC1 NFAT2 NFATC Uterine corpus endometrial carcinoma Phosphorylation N T154 O95644 4772 NFATC1 NFAT2 NFATC Breast invasive carcinoma Phosphorylation N S158 O95644 4772 NFATC1 NFAT2 NFATC Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S158 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N S158 O95644 4772 NFATC1 NFAT2 NFATC Hepatocellular carcinoma Phosphorylation N S158 O95644 4772 NFATC1 NFAT2 NFATC Stomach adenocarcinoma Phosphorylation N S158 O95644 4772 NFATC1 NFAT2 NFATC Uterine corpus endometrial carcinoma Phosphorylation N S158 O95644 4772 NFATC1 NFAT2 NFATC Breast invasive carcinoma Phosphorylation N S161 O95644 4772 NFATC1 NFAT2 NFATC Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S161 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N S161 O95644 4772 NFATC1 NFAT2 NFATC Stomach adenocarcinoma Phosphorylation N S161 O95644 4772 NFATC1 NFAT2 NFATC Lung squamous cell carcinoma Phosphorylation N S233 O95644 4772 NFATC1 NFAT2 NFATC Lung squamous cell carcinoma Phosphorylation N S237 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer Phosphorylation N S237 O95644 4772 NFATC1 NFAT2 NFATC Lung squamous cell carcinoma Phosphorylation N S241 O95644 4772 NFATC1 NFAT2 NFATC Uterine carcinosarcoma Phosphorylation N S241 O95644 4772 NFATC1 NFAT2 NFATC Lung squamous cell carcinoma Phosphorylation C S245 O95644 4772 NFATC1 NFAT2 NFATC Lung squamous cell carcinoma Phosphorylation N S245 O95644 4772 NFATC1 NFAT2 NFATC Uterine carcinosarcoma Phosphorylation N S245 O95644 4772 NFATC1 NFAT2 NFATC Lung squamous cell carcinoma Phosphorylation N S250 O95644 4772 NFATC1 NFAT2 NFATC Uterine carcinosarcoma Phosphorylation N S250 O95644 4772 NFATC1 NFAT2 NFATC Bladder urothelial carcinoma Phosphorylation N S269 O95644 4772 NFATC1 NFAT2 NFATC Lung adenocarcinoma Phosphorylation N S269 O95644 4772 NFATC1 NFAT2 NFATC Bladder urothelial carcinoma Phosphorylation N S278 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N S278 O95644 4772 NFATC1 NFAT2 NFATC Lung adenocarcinoma Phosphorylation N S278 O95644 4772 NFATC1 NFAT2 NFATC Skin cutaneous melanoma Phosphorylation N S278 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N S282 O95644 4772 NFATC1 NFAT2 NFATC Lung adenocarcinoma Phosphorylation N S282 O95644 4772 NFATC1 NFAT2 NFATC Skin cutaneous melanoma Phosphorylation N S282 O95644 4772 NFATC1 NFAT2 NFATC Thyroid carcinoma Phosphorylation N S282 O95644 4772 NFATC1 NFAT2 NFATC Thyroid carcinoma Phosphorylation N S290 O95644 4772 NFATC1 NFAT2 NFATC Thyroid carcinoma Phosphorylation N S294 O95644 4772 NFATC1 NFAT2 NFATC Esophageal adenocarcinoma Phosphorylation N T338 O95644 4772 NFATC1 NFAT2 NFATC Esophageal adenocarcinoma Phosphorylation N T339 O95644 4772 NFATC1 NFAT2 NFATC Esophageal adenocarcinoma Phosphorylation N S345 O95644 4772 NFATC1 NFAT2 NFATC Esophageal adenocarcinoma SUMOylation N K349 O95644 4772 NFATC1 NFAT2 NFATC Bladder urothelial carcinoma Phosphorylation N S359 O95644 4772 NFATC1 NFAT2 NFATC Colon adenocarcinoma Phosphorylation N Y371 O95644 4772 NFATC1 NFAT2 NFATC Hepatocellular carcinoma Ubiquitination N K379 O95644 4772 NFATC1 NFAT2 NFATC Skin cutaneous melanoma Ubiquitination N K398 O95644 4772 NFATC1 NFAT2 NFATC Skin cutaneous melanoma Phosphorylation N S403 O95644 4772 NFATC1 NFAT2 NFATC Skin cutaneous melanoma Phosphorylation N S409 O95644 4772 NFATC1 NFAT2 NFATC Bladder urothelial carcinoma Ubiquitination N K538 O95644 4772 NFATC1 NFAT2 NFATC Bladder urothelial carcinoma Phosphorylation N S542 O95644 4772 NFATC1 NFAT2 NFATC Breast invasive carcinoma Phosphorylation N S670 O95644 4772 NFATC1 NFAT2 NFATC Lung adenocarcinoma Phosphorylation N S670 O95644 4772 NFATC1 NFAT2 NFATC Skin cutaneous melanoma Phosphorylation N S813 O95644 4772 NFATC1 NFAT2 NFATC Prostate adenocarcinoma SUMOylation N K914 Q13546 8737 RIPK1 RIP RIP1 Liver cancer Phosphorylation N S6 Q13546 8737 RIPK1 RIP RIP1 Prostate adenocarcinoma Phosphorylation N S20 Q13546 8737 RIPK1 RIP RIP1 Prostate adenocarcinoma Phosphorylation N S25 Q13546 8737 RIPK1 RIP RIP1 Bladder urothelial carcinoma Ubiquitination N K49 Q13546 8737 RIPK1 RIP RIP1 Stomach adenocarcinoma Ubiquitination N K49 Q13546 8737 RIPK1 RIP RIP1 Head and neck squamous cell carcinoma Ubiquitination N K137 Q13546 8737 RIPK1 RIP RIP1 Breast adenocarcinoma Ubiquitination N K140 Q13546 8737 RIPK1 RIP RIP1 Breast invasive carcinoma Ubiquitination N K140 Q13546 8737 RIPK1 RIP RIP1 Breast adenocarcinoma Ubiquitination N K153 Q13546 8737 RIPK1 RIP RIP1 Breast invasive carcinoma Ubiquitination N K153 Q13546 8737 RIPK1 RIP RIP1 Hepatocellular carcinoma Ubiquitination N K153 Q13546 8737 RIPK1 RIP RIP1 Liver cancer Ubiquitination N K153 Q13546 8737 RIPK1 RIP RIP1 Hepatocellular carcinoma Phosphorylation N S161 Q13546 8737 RIPK1 RIP RIP1 Liver cancer Phosphorylation N S161 Q13546 8737 RIPK1 RIP RIP1 Hepatocellular carcinoma Ubiquitination N K163 Q13546 8737 RIPK1 RIP RIP1 Lung adenocarcinoma Ubiquitination N K185 Q13546 8737 RIPK1 RIP RIP1 Lung adenocarcinoma Phosphorylation N S262 Q13546 8737 RIPK1 RIP RIP1 Sarcoma Ubiquitination N K284 Q13546 8737 RIPK1 RIP RIP1 Sarcoma Phosphorylation N S291 Q13546 8737 RIPK1 RIP RIP1 Bladder urothelial carcinoma Phosphorylation N S303 Q13546 8737 RIPK1 RIP RIP1 Bladder urothelial carcinoma Ubiquitination N K306 Q13546 8737 RIPK1 RIP RIP1 Kidney renal papillary cell carcinoma Ubiquitination N K306 Q13546 8737 RIPK1 RIP RIP1 Bladder urothelial carcinoma Phosphorylation N S309 Q13546 8737 RIPK1 RIP RIP1 Kidney renal papillary cell carcinoma Phosphorylation N S309 Q13546 8737 RIPK1 RIP RIP1 Bladder urothelial carcinoma Ubiquitination N K316 Q13546 8737 RIPK1 RIP RIP1 Kidney renal papillary cell carcinoma Ubiquitination N K316 Q13546 8737 RIPK1 RIP RIP1 Autoinflammation with episodic fever and lymphadenopathy Phosphorylation N S320 Q13546 8737 RIPK1 RIP RIP1 Bladder urothelial carcinoma Phosphorylation N S320 Q13546 8737 RIPK1 RIP RIP1 Glioblastoma multiforme Phosphorylation N S330 Q13546 8737 RIPK1 RIP RIP1 Stomach adenocarcinoma Phosphorylation N S330 Q13546 8737 RIPK1 RIP RIP1 Glioblastoma multiforme Phosphorylation N S331 Q13546 8737 RIPK1 RIP RIP1 Stomach adenocarcinoma Phosphorylation N S331 Q13546 8737 RIPK1 RIP RIP1 Glioblastoma multiforme Phosphorylation N S333 Q13546 8737 RIPK1 RIP RIP1 Stomach adenocarcinoma Phosphorylation N S333 Q13546 8737 RIPK1 RIP RIP1 Glioblastoma multiforme Phosphorylation N S335 Q13546 8737 RIPK1 RIP RIP1 Stomach adenocarcinoma Phosphorylation N S335 Q13546 8737 RIPK1 RIP RIP1 Glioblastoma multiforme Phosphorylation N T337 Q13546 8737 RIPK1 RIP RIP1 Stomach adenocarcinoma Phosphorylation N T337 Q13546 8737 RIPK1 RIP RIP1 Lung adenocarcinoma Phosphorylation N S345 Q13546 8737 RIPK1 RIP RIP1 Skin cutaneous melanoma Phosphorylation N S345 Q13546 8737 RIPK1 RIP RIP1 Lung adenocarcinoma Phosphorylation N S346 Q13546 8737 RIPK1 RIP RIP1 Skin cutaneous melanoma Phosphorylation N S346 Q13546 8737 RIPK1 RIP RIP1 Lung adenocarcinoma Phosphorylation N S357 Q13546 8737 RIPK1 RIP RIP1 Stomach cancer Phosphorylation N Y384 Q13546 8737 RIPK1 RIP RIP1 Head and neck squamous cell carcinoma Phosphorylation N Y387 Q13546 8737 RIPK1 RIP RIP1 Head and neck squamous cell carcinoma Phosphorylation N S389 Q13546 8737 RIPK1 RIP RIP1 Lung adenocarcinoma Phosphorylation N S416 Q13546 8737 RIPK1 RIP RIP1 Sarcoma Phosphorylation N S416 Q13546 8737 RIPK1 RIP RIP1 Skin cutaneous melanoma Phosphorylation N S416 Q13546 8737 RIPK1 RIP RIP1 Brain lower grade glioma Methylation N R477 Q13546 8737 RIPK1 RIP RIP1 Hepatocellular carcinoma Methylation N R487 Q13546 8737 RIPK1 RIP RIP1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K530 Q13546 8737 RIPK1 RIP RIP1 Lung adenocarcinoma Ubiquitination N K571 Q13546 8737 RIPK1 RIP RIP1 Colon adenocarcinoma Ubiquitination N K604 Q13546 8737 RIPK1 RIP RIP1 Colorectal adenocarcinoma Ubiquitination N K604 Q13546 8737 RIPK1 RIP RIP1 Colon adenocarcinoma Phosphorylation N S610 Q13546 8737 RIPK1 RIP RIP1 Colorectal adenocarcinoma Phosphorylation N S610 Q13546 8737 RIPK1 RIP RIP1 Bladder urothelial carcinoma Ubiquitination N K642 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Serine phosphorylation U S151 31730483 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Serine phosphorylation U S153 31730483 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Threonine phosphorylation U T154 31730483 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Serine phosphorylation U S245 31730483 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Serine phosphorylation U S256 31730483 O95644 4772 NFATC1 NFAT2 NFATC Glioblastoma GBM tissues Serine phosphorylation U S261 34309232 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Serine phosphorylation U S269 31730483 O95644 4772 NFATC1 NFAT2 NFATC Glioblastoma GBM tissues Serine phosphorylation U S278 34309232 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Threonine phosphorylation U T338 31730483 O95644 4772 NFATC1 NFAT2 NFATC Prostate cancer PC-3 cell line Threonine phosphorylation U T339 31730483 O95644 4772 NFATC1 NFAT2 NFATC Glioblastoma GBM tissues Serine phosphorylation U S403 34309232 O95644 4772 NFATC1 NFAT2 NFATC Glioblastoma GBM tissues Serine phosphorylation U S409 34309232 Q13546 8737 RIPK1 RIP RIP1 Hepatocellular carcinoma tumor tissue Ubiquitination D K140 37027301 O95644 4772 NFATC1 NFAT2 NFATC Diabetes mellitus Deacetylation D K549 37392543 Q13546 8737 RIPK1 RIP RIP1 Dilated cardiomyopathy Serine phosphorylation A S321 34990405 Q13546 8737 RIPK1 RIP RIP1 Colon cancer HT-29 cells Phosphorylation D 35022391 Q13546 8737 RIPK1 RIP RIP1 Glioblastoma cell line Polyubiquitination U 22585859 Q13546 8737 RIPK1 RIP RIP1 Breast cancer/tumor/carcinoma Ubiquitination U 18570872 Q13546 8737 RIPK1 RIP RIP1 Ovarian cancer/carcinoma Ubiquitination U 18570872 O95644 4772 NFATC1 NFAT2 NFATC Experimental autoimmune encephalomyelitis SUMOylation N K349 32986812 O95644 4772 NFATC1 NFAT2 NFATC Graft-versus-host disease SUMOylation N K349 32986812 O95644 4772 NFATC1 NFAT2 NFATC Experimental autoimmune encephalomyelitis SUMOylation N K702 32986812 O95644 4772 NFATC1 NFAT2 NFATC Graft-versus-host disease SUMOylation N K702 32986812 O95644 4772 NFATC1 NFAT2 NFATC Experimental autoimmune encephalomyelitis SUMOylation N K914 32986812 O95644 4772 NFATC1 NFAT2 NFATC Graft-versus-host disease SUMOylation N K914 32986812 Q13546 8737 RIPK1 RIP RIP1 Multiple sclerosis Serine phosphorylation U S15 25801023 Q13546 8737 RIPK1 RIP RIP1 Graft-versus-host disease Serine phosphorylation U S166 36356302 Q13546 8737 RIPK1 RIP RIP1 Multiple sclerosis Serine phosphorylation U S166 25801023